Sanni TB - Search Results

1

Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma.

Kato Y, Salumbides BC, Wang XF, Qian DZ, Williams S, Wei Y, Sanni TB, Atadja P, Pili R. Kato Y, et al. Among authors: sanni tb. Mol Cancer Ther. 2007 Jan;6(1):70-81. doi: 10.1158/1535-7163.MCT-06-0125. Mol Cancer Ther. 2007. PMID: 17237267

2

Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.

Kato Y, Yoshimura K, Shin T, Verheul H, Hammers H, Sanni TB, Salumbides BC, Van Erp K, Schulick R, Pili R. Kato Y, et al. Among authors: sanni tb. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4538-46. doi: 10.1158/1078-0432.CCR-07-0014. Clin Cancer Res. 2007. PMID: 17671140

3

Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.

Qian DZ, Kato Y, Shabbeer S, Wei Y, Verheul HM, Salumbides B, Sanni T, Atadja P, Pili R. Qian DZ, et al. Clin Cancer Res. 2006 Jan 15;12(2):634-42. doi: 10.1158/1078-0432.CCR-05-1132. Clin Cancer Res. 2006. PMID: 16428510

4

Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors.

Verheul HM, Salumbides B, Van Erp K, Hammers H, Qian DZ, Sanni T, Atadja P, Pili R. Verheul HM, et al. Clin Cancer Res. 2008 Jun 1;14(11):3589-97. doi: 10.1158/1078-0432.CCR-07-4306. Clin Cancer Res. 2008. PMID: 18519793

5

Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model.

Verheul HM, Hammers H, van Erp K, Wei Y, Sanni T, Salumbides B, Qian DZ, Yancopoulos GD, Pili R. Verheul HM, et al. Clin Cancer Res. 2007 Jul 15;13(14):4201-8. doi: 10.1158/1078-0432.CCR-06-2553. Clin Cancer Res. 2007. PMID: 17634549

6

Human NKG2F is expressed and can associate with DAP12.

Kim DK, Kabat J, Borrego F, Sanni TB, You CH, Coligan JE. Kim DK, et al. Among authors: sanni tb. Mol Immunol. 2004 May;41(1):53-62. doi: 10.1016/j.molimm.2004.01.004. Mol Immunol. 2004. PMID: 15140575

7

NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.

Borrego F, Kabat J, Sanni TB, Coligan JE. Borrego F, et al. Among authors: sanni tb. J Immunol. 2002 Dec 1;169(11):6102-11. doi: 10.4049/jimmunol.169.11.6102. J Immunol. 2002. PMID: 12444112

8

Exclusion of lipid rafts and decreased mobility of CD94/NKG2A receptors at the inhibitory NK cell synapse.

Sanni TB, Masilamani M, Kabat J, Coligan JE, Borrego F. Sanni TB, et al. Mol Biol Cell. 2004 Jul;15(7):3210-23. doi: 10.1091/mbc.e03-11-0779. Epub 2004 May 7. Mol Biol Cell. 2004. PMID: 15133125 Free PMC article.

9

The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.

Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE. Borrego F, et al. Among authors: sanni tb. Mol Immunol. 2005 Feb;42(4):485-8. doi: 10.1016/j.molimm.2004.07.031. Mol Immunol. 2005. PMID: 15607803 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters